Related Experiment Video
Updated: May 7, 2026

09:22
Fabricating Superhydrophobic Polymeric Materials for Biomedical Applications
Published on: August 28, 2015
19.1K
Polyhydroxyalkanoates: Medical Applications and Potential for Use in Dentistry
Rim Ben Abdeladhim1, José Alexandre Reis1,2, Ana Maria Vieira1,2
1Egas Moniz School of Health & Science, Campus Universitário, Quinta da Granja, 2829-511 Caparica, Portugal.
Materials (Basel, Switzerland)
|November 27, 2024
Summary
Polyhydroxyalkanoates (PHAs) offer biodegradable and biocompatible alternatives to synthetic polymers. This review explores their medical and dental applications, highlighting innovations in regenerative medicine and drug delivery.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Biotechnology
Background:
- Polyhydroxyalkanoates (PHAs) are biodegradable and biocompatible polyesters produced by microorganisms.
- Growing demand for sustainable plastics fuels the PHA market.
- PHAs offer an eco-friendly alternative to conventional synthetic polymers.
Purpose of the Study:
- To review the medical and dental applications of PHAs.
- To discuss the advantages, disadvantages, and indications of PHA use in healthcare.
- To highlight PHA's potential in regenerative medicine and drug delivery systems.
Main Methods:
- Literature review of scientific publications on PHA applications in medicine and dentistry.
- Analysis of PHA properties relevant to biocompatibility and biodegradability.
- Synthesis of information regarding PHA's role in tissue regeneration, medical devices, and drug encapsulation.
Main Results:
- PHAs show promise in regenerative medicine, including vascular grafts and oral tissue regeneration.
- Applications in dental implants and medical devices are explored.
- PHAs are effective in encapsulating hydrophobic drugs for targeted delivery.
Conclusions:
- PHAs present significant opportunities for advancing medical and dental treatments.
- Their biocompatibility and biodegradability offer sustainable solutions for medical devices.
- Further research can optimize PHA utilization for improved drug delivery and regenerative therapies.

